Skip to main content

Table 4 Incidence of adverse effects in groups of active and placebo probiotic at 7 and 30-day visits

From: Association of a probiotic to a Helicobacter pylorieradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study

Visit Active probiotic Placebo probiotic p
7 day 32/54 (59.3%) 37/52 (71.2%) 0.20
30 day 21/49 (44.9%) 29/48 (60.4%) 0.08
  1. Pearson Chi-Square.